Novo Holdings — Full Portfolio

Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer.

BiotechHealthtechMedical DevicesSan Francisco, US

Dr. Edgar G. Engleman(Founder)

Co-investorsPfizer Venture InvestmentsRA CapitalSamsara BioCapitalSofinnova VenturesVivo CapitalNan Fung Life Sciences+1 more

Hemab is a biotechnology company developing targeted prophylactic therapies for people with serious bleeding and blood coagulation disorders that lack adequate treatment options.

BiotechHealthtech

Co-investorsAccess BiotechnologyAvoro Capital AdvisorsHealthCapSofinnova Partners

Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry.

BiotechClimate TechConstruction TechNew MaterialsResearch Triangle Park, US

Ginger K. Dosier(Executive Officer, Director)Michael F. Noel(Director)John M. Dosier(Executive Officer)

Board seatAnders Bendsen Spohr· per SEC Form D

Co-investorsCarbonCelesta CapitalCelesta Capital

Acesion Pharma is a biotech company developing pharmaceutical treatments.

BiotechHealthtechMedical DevicesCopenhagen, DK

Ulrik Sørensen(COO & Co-founder)Morten Grunnet(CSO & Co-founder)Anders Gaarsdal Holst(CEO & CMO)Torgeir Vaage(CFO)

Co-investorsAlpha Wave GlobalCanaan PartnersBroadview VenturesGlobal BioAccess Fund

Alentis is a biotech company developing therapies for chronic liver disease, fibrosis, and cancer based on the molecular biology of liver disease.

AI & Machine LearningBiotechHealthtechMedical DevicesBasel, CH

Thomas Baumert(Founder)Mark Pruzanski(Chief Executive Officer)Luigi Manenti(Chief Medical Officer)Jon Freve(Chief Financial Officer)Bryan Yoon(General Counsel and Chief Administrative Officer)Aditya Venugopal(Chief Business Officer)

Co-investorsAvego BioScience CapitalBioMedPartnersFrazier Life SciencesJeito CapitalLongitude CapitalOrbiMed+5 more

Amass operates an agentic data platform that unifies over 500 million scientific documents — including research literature, patents, clinical trials, regulatory filings, and web sources — into a single engine that returns answers cited to their source.

AI & Machine LearningBiotechData & Infrastructure

Alexander Junge(Co-Founder & CTO)inHenrik Jensen(Co-Founder & CEO)in

Co-investorsGiant Ventures Global LlpKost Capital

AnaCardio is a Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, with its lead program AC01 in phase 1b/2a clinical development.

BiotechHealthtechMedical DevicesStockholm, SE

Lars H. Lund(Founder)

Co-investors3B Future Health FundIndustrifondenPureos BioventuresSound Bioventures

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

Andrew Schiermeier(Chief Executive Officer)in

Co-investorsBlackstone Life SciencesEight Roads VenturesF-Prime CapitalNYBC Ventures

Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools.

BiotechDeep TechLongevity

Diogo R. Feleciano(Co-Founder & CSO)Darci J. Trader(Scientific Co-Founder / Advisor)João Ribas(Interim-CBO)

Co-investorsApollo Health VenturesKorify Capital

Callio Therapeutics develops next-generation dual-payload antibody-drug conjugates (ADCs) with differentiated payload and linker technologies for targeted cancer treatment.

BiotechMedical DevicesSeattle, US

Piers Ingram(President, Co-Founder)Jerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)Zachary Hornby(Chief Executive Officer)

Co-investorsOmega FundsFrazier Life SciencesJeito CapitalNorwest Venture Partners

Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches.

HealthtechInsurTechSouthern California, US

Myong Sun Lee(Executive Officer, Director)Hiep Dinh Pham(Executive Officer, Director)Dave Firdaus(Executive Officer, Director)

Co-investorsNorwest Venture PartnersGlobal Founders CapitalGV (Google Ventures)AV8 VenturesFigure 8 InvestmentsPruVen Capital Partners+1 more

Crystalys Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for gout, a chronic metabolic disease caused by elevated uric acid.

BiotechHealthtechMedical DevicesSan Diego, US

James Mackay(President & Chief Executive Officer)inNihar Bhakta(Chief Medical Officer)inAshwin Ram(Chief Operating Officer)inDeAnne Reid(Chief Administrative Officer)in

Co-investorsCatalys PacificAN Venture PartnersFrazier Life SciencesLightstone VenturesLongwood Fund

Esco Lifesciences manufactures laboratory and life sciences equipment including biosafety cabinets, incubators, PCR thermal cyclers, and IVF workstations for pharmaceutical, biotechnology, and fertility clinic customers globally.

Advanced ManufacturingBiotechHardwareHealthtechMedical DevicesSingapore, SG

Lim Lay Yew(Founder)Low Yae Foong(Founder)

Co-investorsVivo CapitalGIC

Expedition Therapeutics is a drug development company focused on advancing therapeutic programs in areas such as CAR-T immunotherapy and oncology.

BiotechHealthtechMedical DevicesSan Francisco, US

Yi Larson(Founder and CEO)Geoff Gilmartin(Chief Medical Officer)Eric Hu(Chief Business Officer)

Co-investorsForbionSofinnova VenturesSanofi Ventures

LanzaTech converts carbon-rich gases from industrial sources like steel mills and landfills into fuels and chemicals using synthetic biology.

Circular EconomyCleantechClimate Tech

Dr. Jennifer Holmgren(CEO)

Co-investorsActivant CapitalKhosla VenturesOutset VenturesQiming Venture Partners

MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.

BiotechHealthtech

PerBengt(CSO)

Co-investorsAdjuvant CapitalIndustrifondenOrbiMedPureos BioventuresSanofi VenturesSunstone Capital+2 more

NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions.

BiotechDeep TechHealthtechMedical DevicesAarhus, DK

Co-investorsJeito CapitalRoche Venture FundInkef

Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs.

BiotechDeep TechHealthtechMedical Devices

Ryan Cirz(Co-founder & CEO)Andrew McCandlish(Co-founder & COO)Peter Smith(Chief Scientific Officer)Daniel Cloutier(VP, Development)

Co-investorsTenmile

Ritedose is a contract development and manufacturing organization (CDMO) and generic drug manufacturer specializing in sterile Blow-Fill-Seal (BFS) unit-dose delivery, producing medications such as inhalation and ophthalmic solutions.

Advanced ManufacturingBiotechHealthtechColumbia, US

Jody Chastain(CEO)

Co-investorsOlympus Partners

Subra develops superconductor technologies and integrated platforms covering the value chain from high-temperature superconducting (HTS) coatings to superconducting cable systems for energy applications.

Deep TechEnergyNew MaterialsGermany, DE

Co-investorsBayern KapitalEnBW New Ventures GmbH

Verana Health aggregates de-identified clinical data from a network of over 20,000 physicians in ophthalmology, urology, and neurology to power real-world evidence, clinical trial enablement, and quality reporting for pharmaceutical companies and healthcare providers using AI and machine learning.

AI & Machine LearningData & InfrastructureDigital HealthHealthtech

Sujay Jadhav(Chief Executive Officer)

Co-investorsBreyer CapitalTech Council VenturesValspring CapitalDefine Ventures

ZELP develops technology to measure and reduce methane emissions from the livestock industry.

AgTechClimate TechImpact & Social GoodIoT

Francisco(Co-Founder, CEO)inPatricio(Co-Founder, Chairman of the Board)

Co-investorsCollaborative FundDanone Manifesto VentureStarlight Ventures

HealthtechJacksonville, US

Nathan W. Eastman(Chief Financial Officer, Treasurer)Christopher Hunter(Director)Steve Betts(Director)Earnie Franklin(Director)Aaron Gani(Director)Carl McDonald(Director)

Board seatAbhijeet Lele· per SEC Form D

Co-investorsFrancisco Partners

Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs.

BiotechCircular EconomyCleantechClimate TechNew MaterialsSan Diego, US

Christophe Schilling(Co-founder (former CEO))Bernhard Palsson(Co-founder)Thomas McDonald(Executive Officer)Carlos A. Cabrera(Executive Chairman)John G. Gugel(Chief Executive Officer)Tom McDonald(SVP, Finance & Chief Financial Officer)

Board seatAnders Bendsen Spohr· per SEC Form D · $119.1M raise · filed Aug 2021

Co-investorsVantagePoint Capital PartnersCasdin Capital

MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.

BiotechCircular EconomyNew MaterialsEmeryville, US

Philip Ross(Director)Michael Lindheim(Executive Officer)Matthew Scullin(Executive Officer, Director)

BoardKiersten Stead(Director)inThomas Grotkjaer(Director)

Board seatAnders Bendsen Spohr· per SEC Form D

Co-investorsDCVC (Data Collective)Hemisphere Ventures LLCWireframe Ventures8VCAgFunderDCVC Bio+3 more

Developing a next generation antiarrhythmic drug that targets the SK channel to treat atrial fibrillation without causing significant adverse events.

Co-investorsGlobal BioAccess Fund

Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need.

BiotechMedical Devices

Co-investorsVida VenturesHealthCapJeito CapitalOrbiMedPontifax Venture CapitalRA Capital+2 more

Planetary Health Investments, Asia; invested October 2024

AMSilk develops biogenic silk protein materials designed with AI-powered protein design and produced through precision fermentation, aimed at replacing conventional materials with lower-impact alternatives.

BiotechCircular EconomyNew Materials

Antag Therapeutics develops GIP receptor antagonist therapies for obesity, diabetes, and overweight patients.

BiotechHealthtechCopenhagen, DK

Jens Juul Holst(Founder)Mette Rosenkilde(Founder)

Co-investorsBroadview VenturesSR One Capital Management

Planetary Health Investments; invested February 2023

Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses.

AI & Machine LearningBiotechHealthtechMedical DevicesLund, SE

Cristiana Pires(Co-founder and CEO)Fábio Rosa(Co-founder and VP of Research)Filipe Pereira(Co-founder and Head of Innovation)

Co-investorsIndustrifondenLU InnovationBoehringer Ingelheim Venture Fund

Augustine Therapeutics is a biotech company developing HDAC6-targeted therapies for peripheral neuropathies such as Charcot-Marie-Tooth disease and chemotherapy-induced peripheral neuropathy, as well as neurodegenerative disorders like ALS.

BiotechMedical Devices

Co-investorsAdBio partnersJeito CapitalPMVV-Bio VenturesAsabys Partners

Venture Investments, North America; invested February 2017

Planetary Health Investments, Europe; invested March 2021

BBI Solutions develops and manufactures native and recombinant reagents, antibodies, antigens, enzymes, and gold nanoparticle conjugates for in-vitro diagnostics (IVD) and life sciences teams.

Advanced ManufacturingBiotechMedical Devices

Benchmark Genetics develops and supplies high-performance Atlantic salmon ova and provides genetics and genotyping services for aquaculture producers worldwide, supporting breeding program design and genomic selection.

AgTechBiotechFoodTech

Kristian Botnen(CEO)

Venture Investments, Europe; invested December 2020

BioGeneration Ventures is a venture capital investor focused on early-stage biotech and life sciences companies.

Biotech

Co-investorsBOMKfW Capital

Healthcare company acquired by Mirum Pharmaceuticals, a former RiverVest portfolio company.

San Mateo, US

Keting Chu(Executive Officer, Director)Dajun Yang(Director)Nancy Hong(Director)Alon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)

Co-investorsFrazier Life SciencesRA CapitalRiverVest Venture PartnersHBM Healthcare InvestmentsT. Rowe PriceWellington Management

Activating the immune system to recognize and destroy tumor cells.

BiotechCambridge, US

Art Krieg(Executive Officer, Director)Barry Labinger(Executive Officer, Director)Chuck Abdalian(Executive Officer)David Mauro(Executive Officer)Karen Brennan(Executive Officer)Charles Yon(Executive Officer)

Co-investorsF-Prime CapitalSofinnova VenturesLongitude Capital

Chromologics develops natural red colorants as alternatives to synthetic dyes.

BiotechFoodTechNew MaterialsCopenhagen, DK

Anders Odum(Founder)

Co-investorsBlue Horizon CorporationCollateral GoodNordic Foodtech VCDoehler Ventures

Cirius Therapeutics is a clinical-stage pharmaceutical company developing therapies for patients with chronic metabolic diseases driven by insulin resistance, including Type 2 Diabetes and obesity.

BiotechDigital HealthGrand Rapids, US

Jerry Callahan(Executive Officer)Brian Farmer(Executive Officer)Robert Baltera(Executive Officer, Director)Howard Dittrich(Executive Officer)

BoardMichael Jandernoa(Director)Mark Olesnavage(Executive Officer)

Co-investorsFrazier Healthcare Partners

Claris Bio develops biologic therapies for sight-threatening eye diseases, with a current focus on bringing CSB-001, a novel treatment for patients with limbal stem cell deficiency, through clinical development and to market.

BiotechHealthtechMedical Devices

Clarke Atwell(Co-Founder and Chief Operating Officer)

Co-investorsRA CapitalSofinnova Ventures

BiotechJersey City, US

Henry Rath(Executive Officer)Susan Orr(Executive Officer)Clarke Atwell(Executive Officer, Director)Stephen Brady(Executive Officer, Director)Michael Dybbs(Director)Matt Hobson(Director)

Co-investorsCatalio Capital ManagementSamsara BioCapitalSofinnova Ventures

Clasp Therapeutics develops off-the-shelf precision T cell engagers (its proprietary pHLАre molecules) that target mutant peptide-HLA complexes displayed on cancer cells, directing T cells to destroy tumors carrying common driver mutations such as KRas.

BiotechHealthtechCambridge, US

Co-investorsCatalio Capital Management, LPCure VenturesVivo CapitalCatalio Capital ManagementThird Rock Ventures

Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.

BiotechDeep TechHealthtechMedical DevicesParis, FR

Co-investorsFund+Kurma PartnersSeroba Life SciencesV-Bio VenturesBpifranceInvus+1 more

Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.

AI & Machine LearningBiotech

Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)Marie De Vulder(Chief Legal Officer Co-founder)Guy Peeters(Chief Financial Officer Co-founder)John-Paul Gallivan(Head of Development Co-founder)Fabrice Kolb(Head of Immunology Co-founder)Pieter Peeters(Operating & Technology Officer Co-founder)

Co-investorsLongwood FundSofinnova VenturesBAM ElevateFinchley Healthcare VenturesForbionLuma Group+1 more

Doctor Anywhere is a technology-driven healthcare company that provides medical care to patients through online and in-person channels.

Digital HealthHealthtechMental Health

Co-investorsOSK Ventures InternationalSquare Peg Capital

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtech

Mark Sylvester(Chief Financial Officer)Andrew Warner(Vice President, Product)Monica Zarb(Vice President, Business Development)Durand Van Arnem(Vice President, Engineering)Alan Rope(Medical Director)

Co-investorsCanaan PartnersDreamers VCEcho Health VenturesGV (Google Ventures)Illumina VenturesKaiser Permanente Ventures+3 more

GlycoEra develops glycan-based therapeutics, applying glycoengineering technology to create biologic drugs.

BiotechHealthtechNewton, US

Ganesh V. Kaundinya(President & CEO)in

Co-investors5AM VenturesCatalio Capital Management, LPLifeArc VenturesRoche Venture FundSixty Degree CapitalSofinnova Partners+1 more

HPNow produces hydrogen peroxide (Peroxide UltraPure) on-site through a patented electrochemical process that converts water, electricity, and air into low-concentration, high-purity peroxide for water treatment.

AgTechCircular EconomyCleantechHardwareNew Materials

Co-investorsAP VenturesEvonik Venture Capital GmbH

HST Pathways provides an all-in-one software platform for ambulatory surgery centers (ASCs), covering scheduling, clinical operations (EMR), patient estimates and payments, billing, and data analytics across the full surgical case lifecycle.

Digital HealthHealthtechSaaS

Co-investorsBain Capital Tech OpportunitiesBlue Hour Ventures

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

Piers Ingram(Chief Executive Officer, Co-Founder, Executive Director)Jerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)Konrad Paszkiewicz(Chief Technology Officer)Kwek Kon Yew(Chief Medical Officer)Dipti Thakkar(Chief Operating Officer)

Co-investorsAltium CapitalClavystBioDecheng CapitalDroia VenturesFrazier Life SciencesKiwoom Investment+2 more

Inspirna is a clinical-stage biopharmaceutical company developing first-in-class cancer therapeutics, including oral small molecules and biologics that target newly discovered drivers of metastasis in common cancers such as colorectal, non-small cell lung, and endometrial cancer.

BiotechHealthtechNew York, US

Co-investorsSofinnova PartnersStart CapitalVivo CapitalSands Capital Ventures

Kebotix uses artificial intelligence, machine learning, and laboratory automation to discover and develop new materials and molecules.

AI & Machine LearningDeep TechNew MaterialsCambridge, US

Dennis Sheberla(Executive Officer)Semion Saykin(Executive Officer)Alan Aspuru-Guzik(Executive Officer)inAshish Kulkarni(Executive Officer, Director)

BoardTong Hui(Director)Andrew Krowne(Director)in

Co-investorsArcTern VenturesBantam GroupFlybridge Capital PartnersOne Way VenturesPropagator VenturesSafar Partners+3 more

Kivu Bioscience is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology, using site-specific conjugation technology to create more stable and homogeneous cancer therapies with reduced off-tumor toxicity.

BiotechDeep TechHealthtech

Mohit Trikha(CEO)

Co-investorsBOMHealthCapM VenturesRed Tree VentureBioGeneration Ventures

Portfolio company acquired by Lilly

Myricx is a biotech company developing a new class of payloads for antibody drug conjugates (ADCs) based on inhibitors of N-myristoyltransferase (NMT) enzymes, aimed at treating cancer.

BiotechMedical DevicesLondon, GB

Co-investorsBrandon Capital PartnersSofinnova Partners

BiotechBoston, US

David Donabedian(Executive Officer, Director)Robert Hadfield(Executive Officer)inJohn McCabe(Executive Officer)in

BoardChristoph Westphal(Director)Ming Cheah(Director)Raymond Camahort(Director)

Co-investorsDCVC (Data Collective)DCVC BioLongwood Fund

Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies.

BiotechHealthtechCopenhagen, DK

Maziar Mike Doustdarin

Co-investorsHM Venture Partners

OXB is a contract development and manufacturing organization (CDMO) providing end-to-end services for cell and gene therapies, with expertise in lentiviral vectors, AAV, adenovirus, and other viral vector manufacturing.

BiotechDeep TechHealthtechOxford, GB

Co-investorsOberland Capital

Qure.ai builds deep learning and AI software to detect and manage diseases such as lung cancer, tuberculosis, pediatric TB, and stroke, with several FDA-cleared solutions.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investorsCrane Venture PartnersLightspeed Venture PartnersHealthQuadKae CapitalMerck Global Health Innovation FundSequoia Capital

Rappta Therapeutics develops small molecule compounds that reactivate protein phosphatase 2A (PP2A) to treat cancer by restoring the enzyme's tumor suppressor function.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsAdvent Life SciencesNovartis Venture Fund

Co-investorsNorwest Venture Partners

Recursion applies artificial intelligence and large-scale data analysis to accelerate drug discovery and development.

AI & Machine LearningBiotechDeep TechMedical DevicesSalt Lake City, US

Chris Gibson(Co-founder, Chairman of the Board)

Co-investorsDCVC (Data Collective)Lux CapitalBaillie GiffordAir Street CapitalAmplify PartnersCatalio Capital Management, LP+8 more

Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.

BiotechDigital HealthMental HealthMorristown, US

Sahil V. Kirpekar(President and CEO)Gregory Mayes(Executive Officer, Director)Ellen Lubman(Director)Mark Pollack(Executive Officer)inNathan Bryson(Executive Officer)inMark Theeuwes(Executive Officer)in

Co-investorsFemHealth VenturesMitsui Global InvestmentMPM BioImpact

Deep tech company; invested from Fund I in 2015

BiotechBozeman, US

Justin DuBois(Director)George Miljanich(Executive Officer)Stan Abel(Executive Officer, Director)

BoardWill Price(Director)inLowell Sears(Director)Joseph Zakrzewski(Director)

Co-investorsNext Frontier CapitalMission BiocapitalOrbiMed

Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.

HardwareHealthtechMedical DevicesCampbell, US

Nitin Salunke(President & CEO)Jean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)

BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)

Co-investors415 CapitalAmed VenturesThe Capital PartnershipUnorthodox Ventures

Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry.

BiotechDeep TechSouth San Francisco, US

Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)

BoardMichael Goller(Director)Reid Huber(Director)inPeter Thompson(Director)

Co-investorsEcoR1 CapitalOrbiMedRA CapitalOsage University PartnersThird Rock Ventures

Tribune Therapeutics is a preclinical biopharmaceutical company developing medicines that target CCN protein family signaling (such as CCN2/CTGF) to block fibrotic pathways.

BiotechHealthtech

Ole Kaasbøll(Co-founder)

Co-investorsHealthCapIndustrifondenLifeArc VenturesInvestinor

WCG provides clinical trial services including institutional review board (IRB) review, site enablement, data and insights, and AI-enabled software for sponsors, CROs, and research sites.

AI & Machine LearningBiotechHealthtech

Co-investorsLeonard Green

Windward Bio is a clinical-stage biotechnology company developing long-acting monoclonal and bispecific antibodies for serious immunological conditions such as asthma, COPD, and dermatological diseases.

BiotechHealthtech

Co-investorsOrbiMedQuan CapitalRA CapitalSanofi VenturesSR One Capital ManagementJanus Henderson Investors+3 more